兽药GMP外用杀虫剂(液体,D级)生产线 - 立健(广东)动保

立健(广东)动保：专注兽药GMP外用杀虫剂(液体,D级)生产线

立健(广东)动物保健有限公司(以下简称'立健动保')是由立家医药集团和健源医药集团共同投资成立的合资公司，双方分别持股51%和49%，于2023年2月1日正式成立。2023年2月17日，立健动保与立家药业新疆公司签署了重组协议，收购其动物保健业务相关的资产。

立家集团和健源医药集团均在人药领域拥有丰富的经验和雄厚的综合实力。着眼于动物保健产品的特点和广阔的市场前景，此次合作将整合双方资源优势，建立核心研发管线，发力动物保健领域，加快业务布局和推广。立健动保将致力于打造兽药GMP外用杀虫剂(液体,D级)生产线，为广大养殖户提供安全、高效、优质的动物保健产品。'}

英文翻译：

{'title': 'Veterinary Drug GMP External Antiparasitic (Liquid, Class D) Production Line - Lijian Animal Health (Guangdong)','description': 'Lijian Animal Health (Guangdong) leverages the extensive experience and strong capabilities of Lijia Pharmaceutical Group and Health Origin Pharmaceutical Group in human medicine to focus on the research, development, and production of Veterinary Drug GMP external antiparasitic (liquid, Class D) production lines, committed to becoming a leading enterprise in the field of animal health.','keywords': 'Veterinary Drug GMP, External Antiparasitic, Liquid Antiparasitic, Class D Veterinary Drug, Lijian Animal Health, Lijia Group, Health Origin','content': '## Lijian Animal Health (Guangdong): Focusing on Veterinary Drug GMP External Antiparasitic (Liquid, Class D) Production Line

Lijian (Guangdong) Animal Health Co., Ltd. (hereinafter referred to as 'Lijian Animal Health') is a joint venture established by Lijia Pharmaceutical Group and Health Origin Pharmaceutical Group, with respective shareholdings of 51% and 49%. The company was officially established on February 1, 2023. On February 17, 2023, Lijian Animal Health signed a restructuring agreement with Lijia Pharmaceutics Xinjiang, acquiring assets related to the animal health business.

Both Lijia Group and Health Origin Pharmaceutical Group have extensive experience and strong comprehensive strength in the field of human medicine. Focusing on the characteristics and broad market prospects of animal health products, this cooperation will integrate the resource advantages of both parties, establish core research and development pipelines, and accelerate business layout and promotion in the field of animal health. Lijian Animal Health will be committed to building a Veterinary Drug GMP external antiparasitic (liquid, Class D) production line, providing safe, efficient, and high-quality animal health products for the majority of farmers.